Home » Molecular Diagnostics and NAT Market
Molecular Diagnostics and NAT Market
Published date: Mar 2022 •Formats:
Request Sample Schedule a Call

Global Molecular Diagnostics and NAT Market By Type (Amplification Technologies, Amplified Gene Detection Technologies, DNA And Oligonucleotide Microarrays, and Others), By Application (Hospitals and Clinics, Research Institutes, Diagnostic Centers), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019-2028

  • Published date: Mar 2022
  • Report ID: 27814
  • Number of Pages: 239
  • Format:
  • keyboard_arrow_up
    • 1. Global Molecular Diagnostics and NAT Market Introduction
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
    • 2. Executive Summary
      • 2.1. Key Findings by Major Segments
      • 2.2. Top strategies by Major Players
    • 3. Global Molecular Diagnostics and NAT Market Overview
      • 3.1. Global Molecular Diagnostics and NAT Market Dynamics
        • 3.1.1. Drivers
        • 3.1.2. Opportunities
        • 3.1.3. Restraints
        • 3.1.4. Challenges
      • 3.2. PESTLE Analysis
      • 3.3. Opportunity Map Analysis
      • 3.4. PORTER'S Five Forces Analysis
      • 3.5. Market Competition Scenario Analysis
      • 3.6. Product Life Cycle Analysis
      • 3.7. Opportunity Orbits
      • 3.8. Manufacturer Intensity Map
    • 4. Global Molecular Diagnostics and NAT Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
      • 4.1. Global Molecular Diagnostics and NAT Market Analysis by Type: Introduction
      • 4.2. Market Size and Forecast by Region
      • 4.3. Amplification Technologies
      • 4.4. Amplified Gene Detection Technologies
      • 4.5. DNA And Oligonucleotide Microarrays
      • 4.6. Gene Sequencing
    • 5. Global Molecular Diagnostics and NAT Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
      • 5.1. Global Molecular Diagnostics and NAT Market Analysis by Application: Introduction
      • 5.2. Market Size and Forecast by Region
      • 5.3. Hospitals and Clinics
      • 5.4. Research Institutes
      • 5.5. Diagnostic Centers
    • 6. Global Molecular Diagnostics and NAT Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
      • 6.1. North America
        • 6.1.1. North America Global Molecular Diagnostics and NAT Market: Regional Trend Analysis
          • 6.1.1.1. US
          • 6.1.1.2. Canada
          • 6.1.1.3. Mexico
      • 6.2.1. Europe
        • 6.2.1. Europe Global Molecular Diagnostics and NAT Market: Regional Trend Analysis
          • 6.2.1.1. Germany
          • 6.2.1.2. France
          • 6.2.1.3. UK
          • 6.2.1.4. Russia
          • 6.2.1.5. Italy
          • 6.2.1.6. Rest of Europe
      • 6.3. Asia-Pacific
        • 6.3.1. Asia-Pacific Global Molecular Diagnostics and NAT Market: Regional Trend Analysis
          • 6.3.1.1. China
          • 6.3.1.2. Japan
          • 6.3.1.3. Korea
          • 6.3.1.4. India
          • 6.3.1.5. Rest of Asia
      • 6.4. Latin America
        • 6.4.1. Latin America Global Molecular Diagnostics and NAT Market: Regional Trend Analysis
          • 6.4.1.1. Brazil
          • 6.4.1.2. Argentina
          • 6.4.1.3. Rest of Latin America
      • 6.5. Middle East and Africa
        • 6.5.1. Middle East and Africa Global Molecular Diagnostics and NAT Market: Regional Trend Analysis
          • 6.5.1.1. GCC
          • 6.5.1.2. South Africa
          • 6.5.1.3. Israel
          • 6.5.1.4. Rest of MEA
    • 7. Global Molecular Diagnostics and NAT Market Competitive Landscape, Market Share Analysis, and Company Profiles
      • 7.1. Market Share Analysis
      • 7.2. Company Profiles
      • 7.3. Roche
        • 7.3.1. Company Overview
        • 7.3.2. Financial Highlights
        • 7.3. 3. Product Portfolio
        • 7.3.4. SWOT Analysis
        • 7.3.5. Key Strategies and Developments
      • 7.4. Abbott
        • 7.4.1. Company Overview
        • 7.4.2. Financial Highlights
        • 7.4.3. Product Portfolio
        • 7.4. 4. SWOT Analysis
        • 7.4.5. Key Strategies and Developments
      • 7.5. BD
        • 7.5.1. Company Overview
        • 7.5.2. Financial Highlights
        • 7.5.3. Product Portfolio
        • 7.5.4. SWOT Analysis
        • 7.5. 5. Key Strategies and Developments
      • 7.6. Biomerieux
        • 7.6.1. Company Overview
        • 7.6.2. Financial Highlights
        • 7.6.3. Product Portfolio
        • 7.6.4. SWOT Analysis
        • 7.6.5. Key Strategies and Developments
      • 7.7. Qiagen
        • 7.7.1. Company Overview
        • 7.7.2. Financial Highlights
        • 7.7.3. Product Portfolio
        • 7.7.4. SWOT Analysis
        • 7.7.5. Key Strategies and Developments
      • 7.8. Thermo Fisher Scientific
        • 7.8.1. Company Overview
        • 7.8.2. Financial Highlights
        • 7.8.3. Product Portfolio
        • 7.8.4. SWOT Analysis
        • 7.8.5. Key Strategies and Developments
      • 7.9. Agilent
        • 7.9.1. Company Overview
        • 7.9.2. Financial Highlights
        • 7.9.3. Product Portfolio
        • 7.9.4. SWOT Analysis
        • 7.9.5. Key Strategies and Developments
      • 7. 10.GenMark
        • 7. 10.1. Company Overview
        • 7. 10.2. Financial Highlights
        • 7. 10.3. Product Portfolio
        • 7. 10.4. SWOT Analysis
        • 7. 10.5. Key Strategies and Developments
      • 7. 11. Siemens Healthcare
        • 7. 11.1. Company Overview
        • 7. 11.2. Financial Highlights
        • 7. 11.3. Product Portfolio
        • 7. 11.4. SWOT Analysis
        • 7. 11.5. Key Strategies and Developments
      • 7. 12. AutoGenomics
        • 7. 12.1. Company Overview
        • 7. 12.2. Financial Highlights
        • 7. 12.3. Product Portfolio
        • 7. 12.4. SWOT Analysis
        • 7. 12.5. Key Strategies and Developments
    • 8. Assumptions and Acronyms
    • 9. Research Methodology
    • 10.Contact
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Molecular Diagnostics and NAT Market
  • 27814
  • Mar 2022
    • ★★★★★
      ★★★★★
    • (9)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
 Multi User
$7,999
$3,499
USD / per unit
save 55%
 Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
Find Help
Legal
Explore